{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:43:46Z","timestamp":1783608226718,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,10,13]],"date-time":"2007-10-13T00:00:00Z","timestamp":1192233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s12033-007-9008-5","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T13:28:25Z","timestamp":1183037305000},"page":"109-119","source":"Crossref","is-referenced-by-count":17,"title":["Naked Plasmid DNA-Based \u03b1-Galactosidase A Gene Transfer Partially Reduces Systemic Accumulation of Globotriaosylceramide in Fabry Mice"],"prefix":"10.1007","volume":"38","author":[{"given":"Gen","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Shimotori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigemi","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok B.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitake","family":"Gejyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,10,13]]},"reference":[{"key":"9008_CR1","first-page":"3733","volume-title":"The metabolic and molecular bases of inherited disease","author":"R. J. Desnick","year":"2001","unstructured":"Desnick R. J., Ionnou Y. A., & Eng C. M. (2001). \u03b1-Galactosidase A deficiency: Fabry disease, In Scriver C. R., Beaudet A. L., Sly W. S., & Valle D., Eds., The metabolic and molecular bases of inherited disease, 8th ed. (pp. 3733\u20133774). New York: McGraw-Hill.","edition":"8th"},{"key":"9008_CR2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"R. O. Brady","year":"1967","unstructured":"Brady, R. O., Gal, A. E., Bradley, R. M., Martensson, E., Warshaw, A. L., & Laster, L. (1967). Enzymatic defect in Fabry\u2019s disease. Ceramidetrihexosidase deficiency. New England Journal of Medicine, 276, 1163\u20131167.","journal-title":"New England Journal of Medicine"},{"key":"9008_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000247189","volume":"187","author":"M. C. Marguery","year":"1993","unstructured":"Marguery, M. C., Giordano, F., Parant, M., Samalens, G., Levade, T., Salvayre, R., Maret, A., Calvas, P., Bourrouillou, G., & Cantala, P. (1993). Fabry\u2019s disease: Heterozygous form of different expression in two monozygous twin sisters. Dermatology, 187, 9\u201315.","journal-title":"Dermatology"},{"key":"9008_CR4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","volume":"24","author":"C. Whybra","year":"2001","unstructured":"Whybra, C., Kampmann, C., Willers, I., Davies, J., Winchester, B., Kriegsmann, J., Bruhl, K., Gal, A., Bunge, S., & Beck, M. (2001). Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. Journal of Inherited Metabolic Disease, 24, 715\u2013724.","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"9008_CR5","doi-asserted-by":"crossref","first-page":"13777","DOI":"10.1073\/pnas.222221899","volume":"99","author":"H. Takahashi","year":"2002","unstructured":"Takahashi, H., Hirai, Y., Migita, M., Seino, Y., Fukuda, Y., Sakuraba, H., Kase, R., Kobayashi, T., & Hashimoto, Y. (2002). Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer. Proceedings of the National Academy of Sciences of the United States of America, 99, 13777\u201313782.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9008_CR6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/360749a0","volume":"360","author":"J. H. Wolfe","year":"1992","unstructured":"Wolfe, J. H., Sands, M. S., Barker, J. E., Gwynn, B., Rowe, L. B., Vogler, C. A., & Birkenmeier, E. H. (1992). Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature, 360, 749\u2013753.","journal-title":"Nature"},{"key":"9008_CR7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0925-4439(94)00082-2","volume":"1270","author":"S. Ishii","year":"1995","unstructured":"Ishii, S., Kase, R., & Sakuraba, H. (1995). The functional role of glutamine-280 and threonine-282 in human alpha-galactosidase. Biochimica et Biophysica Acta, 1270, 163\u2013167.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9008_CR8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/10430340252939041","volume":"13","author":"R. J. Ziegler","year":"2002","unstructured":"Ziegler, R. J., Li, C., Cherry, M., Zhu, Y., Hempel, D., van Rooijen, N., Ioannou, Y. A., Desnick, R. J., Goldberg, M. A., Yew, N. S., & Cheng, S. H. (2002). Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease. Human Gene Therapy, 13, 935\u2013945.","journal-title":"Human Gene Therapy"},{"key":"9008_CR9","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1073\/pnas.051634498","volume":"98","author":"S. C. Jung","year":"2001","unstructured":"Jung, S. C., Han, I. P., Limaye, A., Xu, R., Gelderman, M. P., Zerfas, P., Tirumalai, K., Murray, G. J., During, M. J., Brady, R. O., & Qasba, P. (2001). Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice. Proceedings of the National Academy of Sciences of the United States of America, 98, 2676\u20132681.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9008_CR10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymthe.2003.11.015","volume":"9","author":"R. J. Ziegler","year":"2004","unstructured":"Ziegler, R. J., Lonning, S. M., Armentano, D., Li, C., Souza, D. W., Cherry, M., Ford, C., Barbon, C. M., Desnick, R. J., Gao, G., Wilson, J. M., Peluso, R., Godwin, S., Carter, B. J., Gregory, R. J., Wadworth, S. C., & Cheng, S. H. (2004). AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice. Molecular Therapy, 9, 231\u2013240.","journal-title":"Molecular Therapy"},{"key":"9008_CR11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1006\/mthe.2002.0605","volume":"5","author":"C. Li","year":"2002","unstructured":"Li, C., Ziegler, R. J., Cherry, M., Desnick, R. J., Yew, N. S., & Cheng, S. H. (2002). Adenovirus-transduced lung as a portal for delivering alpha-galactosidase A into systemic circulation for Fabry disease. Molecular Therapy, 5, 745\u2013754.","journal-title":"Molecular Therapy"},{"key":"9008_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jgm.468","volume":"6","author":"M. Przybylska","year":"2004","unstructured":"Przybylska, M., Wu, I. H., Zhao, H., Ziegler, R. J., Tousignant, J. D., Desnick, R. J., Scheule, R. K., Cheng, S. H., & Yew, N. S. (2004). Partial correction of the alpha-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors. Journal of Gene Medicine, 6, 85\u201392.","journal-title":"Journal of Gene Medicine"},{"key":"9008_CR13","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1073\/pnas.0407572101","volume":"101","author":"M. Yoshimitsu","year":"2004","unstructured":"Yoshimitsu, M., Sato, T., Tao, K., Walia, J. S., Rasaiah, V. I., Sleep, G. T., Murray, G. J., Poeppl, A. G., Underwood, J., West, L., Brady, R. O., & Medin, J. A. (2004). Bioluminescent imaging of a marking transgene and correction of Fabry mice by neonatal injection of recombinant lentiviral vectors. Proceedings of the National Academy of Sciences of the United States of America, 101, 16909\u201316914.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9008_CR14","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1073\/pnas.0537900100","volume":"100","author":"J. Park","year":"2003","unstructured":"Park, J., Murray, G. J., Limaye, A., Quirk, J. M., Gelderman, M. P., Brady, R. O., & Qasba, P. (2003). Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer. Proceedings of the National Academy of Sciences of the United States of America, 100, 3450\u20133454.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9008_CR15","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1089\/10430349950017671","volume":"10","author":"R. J. Ziegler","year":"1999","unstructured":"Ziegler, R. J., Yew, N. S., Li, C., Cherry, M., Berthelette, P., Romanczuk, H., Ioannou, Y. A., Zeidner, K. M., Desnick, R. J., & Cheng, S. H. (1999). Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer. Human Gene Therapy, 10, 1667\u20131682.","journal-title":"Human Gene Therapy"},{"key":"9008_CR16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ymthe.2005.02.032","volume":"12","author":"M. D. Lavigne","year":"2005","unstructured":"Lavigne, M. D., Pohlschmidt, M., Novo, J. F., Higgins, B., Alakhov, V., Lochmuller, H., Sakuraba, H., Goldspink, G., MacDermot, K., & Gorecki, D. C. (2005). Promoter dependence of plasmid-pluronics targeted alpha galactosidase A expression in skeletal muscle of Fabry mice. Molecular Therapy, 12, 985\u2013990.","journal-title":"Molecular Therapy"},{"issue":"Suppl 2","key":"9008_CR17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.ASN.0000016683.73778.78","volume":"13","author":"M. Branton","year":"2002","unstructured":"Branton, M., Schiffmann, R., & Kopp, J. B. (2002). Natural history and treatment of renal involvement in Fabry disease. Journal of the American Society of Nephrology, 13(Suppl 2), 139\u2013143.","journal-title":"Journal of the American Society of Nephrology"},{"key":"9008_CR18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"M. H. Branton","year":"2002","unstructured":"Branton, M. H., Schiffmann, R., Sabnis, S. G., Murray, G. J., Quirk, J. M., Altarescu, G., Goldfarb, L., Brady, R. O., Balow, J. E., Austin, H. A. III, & Kopp, J. B. (2002). Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine, 81, 122\u2013138.","journal-title":"Medicine"},{"key":"9008_CR19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/10430340252792585","volume":"13","author":"H. Maruyama","year":"2002","unstructured":"Maruyama, H., Higuchi, N., Nishikawa, Y., Hirahara, H., Iino, N., Kameda, S., Kawachi, H., Yaoita, E., Gejyo, F., & Miyazaki, J. (2002). Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats. Human Gene Therapy, 13, 455\u2013468.","journal-title":"Human Gene Therapy"},{"key":"9008_CR20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbrc.2003.12.107","volume":"314","author":"S. Kameda","year":"2004","unstructured":"Kameda, S., Maruyama, H., Higuchi, N., Iino, N., Nakamura, G., Miyazaki, J., & Gejyo, F. (2004). Kidney-targeted naked DNA transfer by retrograde injection into the renal vein in mice. Biochemical and Biophysical Research Communications, 314, 390\u2013395.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9008_CR21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","volume":"108","author":"H. Niwa","year":"1991","unstructured":"Niwa, H., Yamamura, K., & Miyazaki, J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene, 108, 193\u2013199.","journal-title":"Gene"},{"key":"9008_CR22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/10430340050015897","volume":"11","author":"H. Maruyama","year":"2000","unstructured":"Maruyama, H., Sugawa, M., Moriguchi, Y., Imazeki, I., Ishikawa, Y., Ataka, K., Hasegawa, S., Ito, Y., Higuchi, N., Kazama, J. J., Gejyo, F., & Miyazaki, J. (2000). Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation. Human Gene Therapy, 11, 429\u2013437.","journal-title":"Human Gene Therapy"},{"key":"9008_CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0167-4838(94)90017-5","volume":"1204","author":"S. Ishii","year":"1994","unstructured":"Ishii, S., Kase, R., Sakuraba, H., Fujita, S., Sugimoto, M., Tomita, K., Semba, T., & Suzuki, Y. (1994). Human alpha-galactosidase gene expression: significance of two peptide regions encoded by exons 1\u20132 and 6. Biochimica et Biophysica Acta, 1204, 265\u2013270.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9008_CR24","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","volume":"94","author":"T. Ohshima","year":"1997","unstructured":"Ohshima, T., Murray, G. J., Swaim, W. D., Longenecker, G., Quirk, J. M., Cardarelli, C. O., Sugimoto, Y., Pastan, I., Gottesman, M. M., Brady, R. O., & Kulkarni, A. B. (1997). Alpha-galactosidase A deficient mice: A model of Fabry disease. Proceedings of the National Academy of Sciences of the United States of America, 94, 2540\u20132544.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9008_CR25","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bbadis.2004.07.001","volume":"1690","author":"S. Ishii","year":"2004","unstructured":"Ishii, S., Yoshioka, H., Mannen, K., Kulkarni, A. B., & Fan, J. Q. (2004). Transgenic mouse expressing human mutant alpha-galactosidase A in an endogenous enzyme deficient background: A biochemical animal model for studying active-site specific chaperone therapy for Fabry disease. Biochimica et Biophysica Acta, 1690, 250\u2013257.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9008_CR26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","volume":"5","author":"J. Q. Fan","year":"1999","unstructured":"Fan, J. Q., Ishii, S., Asano, N., & Suzuki, Y. (1999). Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nature Medicine, 5, 112\u2013115.","journal-title":"Nature Medicine"},{"key":"9008_CR27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0009-8981(81)90384-3","volume":"112","author":"J. S. Mayes","year":"1981","unstructured":"Mayes, J. S., Scheerer, J. B., Sifers, R. N., & Donaldson, M.L. (1981). Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry\u2019s disease. Clinica Chimica Acta., 112, 245\u2013251.","journal-title":"Clinica Chimica Acta."},{"key":"9008_CR28","doi-asserted-by":"crossref","first-page":"13112","DOI":"10.1016\/S0021-9258(18)43014-1","volume":"256","author":"R. H. McCluer","year":"1981","unstructured":"McCluer, R. H., Williams, M. A., Gross S. K., & Meisler, M. H., (1981). Testosterone effects on the induction and urinary excretion of mouse kidney glycosphingolipids associated with lysosomes. Journal of Biological Chemistry, 256, 13112\u201313120.","journal-title":"Journal of Biological Chemistry"},{"key":"9008_CR29","unstructured":"Pharmaceuticals and Medical Devices Agency for Evaluation of Medicinal Products. January 2004, http:\/\/www.info.pmda.go.jp\/shinyaku\/g040106\/index.html?submit=%C9%BD%BC%A8."},{"key":"9008_CR30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","volume":"68","author":"Y. A. Ioannou","year":"2001","unstructured":"Ioannou, Y. A., Zeidner, K. M., Gordon, R. E., & Desnick, R. J. (2001). Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice. American Journal of Human Genetics, 68, 14\u201325.","journal-title":"American Journal of Human Genetics"},{"issue":"Suppl 2","key":"9008_CR31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1023\/A:1012451320105","volume":"24","author":"R. O. Brady","year":"2001","unstructured":"Brady, R. O., Murray, G. J., Moore, D. F., & Schiffmann, R. (2001). Enzyme replacement therapy in Fabry disease. Journal of Inherited Metabolic Disease, 24(Suppl 2), 18\u201324.","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"9008_CR32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/glycob\/cwg034","volume":"13","author":"K. Lee","year":"2003","unstructured":"Lee, K., Jin, X., Zhang, K., Copertino, L., Andrews, L., Baker-Malcolm, J., Geagan, L., Qiu, H., Seiger, K., Barngrover, D., McPherson, J. M., & Edmunds, T. (2003). A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease. Glycobiology, 13, 305\u2013313.","journal-title":"Glycobiology"},{"key":"9008_CR33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1357-4310(00)01810-4","volume":"6","author":"P. E. R. J. Monahan Samulski","year":"2000","unstructured":"Monahan, P. E. & Samulski, R. J. (2000). Adeno-associated virus vectors for gene therapy: More pros than cons?. Molecular Medicine Today, 6, 433\u2013440.","journal-title":"Molecular Medicine Today"},{"key":"9008_CR34","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","volume":"6","author":"N. Chirmule","year":"1999","unstructured":"Chirmule, N., Propert, K., Magosin, S., Qian, Y., Qian, R., & Wilson, J. (1999). Immune responses to adenovirus and adeno-associated virus in humans. Gene Therapy, 6, 1574\u20131583.","journal-title":"Gene Therapy"},{"key":"9008_CR35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","volume":"337","author":"S. C. D. N. Garman Garboczi","year":"2004","unstructured":"Garman, S. C. & Garboczi, D. N. (2004). The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. Journal of Molecular Biology, 337, 319\u2013335.","journal-title":"Journal of Molecular Biology"},{"key":"9008_CR36","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R. Schiffmann","year":"2001","unstructured":"Schiffmann, R., Kopp, J. B., Austin, H. A., Sabnis, S., Moore, D. F., Weibel, T., Balow, J. E., & Brady, R. O. (2001). Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA\u2014Journal of the American Medical Association, 285, 2743\u20132749.","journal-title":"JAMA\u2014Journal of the American Medical Association"},{"issue":"Suppl 1","key":"9008_CR37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1523-1755.2002.0610s1052.x","volume":"61","author":"A. S. Stern","year":"2002","unstructured":"Stern, A. S., Klotman, M. E., Ioannou, Y. A., Burrow, C. R., Wilson, P. D., Klotman, P. E., & Lipkowitz, M. S. (2002). Polarity of alpha-galactosidase A uptake by renal tubule cells. Kidney International, 61(Suppl 1), 52\u201355.","journal-title":"Kidney International"},{"key":"9008_CR38","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1046\/j.1523-1755.2002.00675.x","volume":"62","author":"B. L. Thurberg","year":"2002","unstructured":"Thurberg, B. L., Rennke, H., Colvin, R. B., Dikman, S., Gordon, R. E., Collins, A. B., Desnick, R. J., & O\u2019callaghan, M. (2002). Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney International, 62, 1933\u20131946.","journal-title":"Kidney International"},{"key":"9008_CR39","first-page":"353","volume-title":"Brenner & Rector\u2019s The kidney 7th ed","author":"D. A. B. M. Maddox Brenner","year":"2000","unstructured":"Maddox D. A. & Brenner, B. M. (2000). Glomerular ultrafiltration, in Elements of normal renal structure and function, vol. 1. In Brenner B. M. (Ed.), Brenner & Rector\u2019s The kidney 7th ed. (pp. 353\u2013412). Philadelphia: WB Saunders."},{"key":"9008_CR40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymthe.2004.04.009","volume":"10","author":"P. Ye","year":"2004","unstructured":"Ye, P., Thompson, A. R., Sarkar, R., Shen, Z., Lillicrap, D. P., Kaufman, R. J., Ochs, H. D., Rawlings, D. J., & Miao, C. H. (2004). Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice. Molecular Therapy, 10, 117\u2013126.","journal-title":"Molecular Therapy"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-007-9008-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12033-007-9008-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-007-9008-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T05:56:51Z","timestamp":1629093411000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12033-007-9008-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,13]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["9008"],"URL":"https:\/\/doi.org\/10.1007\/s12033-007-9008-5","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,13]]}}}